Sabal Trust CO Pfizer Inc Transaction History

Sabal Trust CO

$1.83 Billion
Q3 2024

A detailed history of Sabal Trust CO transactions in Pfizer Inc stock. As of the latest transaction made, Sabal Trust CO holds 841,870 shares of PFE stock, worth $22.1 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares

841,870

Previous 852,564 1.25%

Holding current value

$22.1 Million

Previous $23.9 Million 2.13%

% of portfolio

1.33%

Previous 1.42%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$27.7 - $31.39 $296,223 - $335,684	-10,694 Reduced 1.25%	841,870 $24.4 Million
Q2 2024 Jul 30, 2024	SELL	$25.26 - $29.6 $773,587 - $906,500	-30,625 Reduced 3.47%	852,564 $23.9 Million
Q1 2024 May 03, 2024	SELL	$25.89 - $29.73 $302,887 - $347,811	-11,699 Reduced 1.31%	883,189 $24.5 Million
Q4 2023 Jan 24, 2024	BUY	$26.13 - $33.94 $483,222 - $627,652	18,493 Added 2.11%	894,888 $25.8 Million
Q3 2023 Oct 10, 2023	BUY	$32.09 - $37.51 $140,008 - $163,656	4,363 Added 0.5%	876,395 $29.1 Million
Q2 2023 Jul 20, 2023	BUY	$36.12 - $41.79 $512,037 - $592,415	14,176 Added 1.65%	872,032 $32 Million
Q1 2023 Apr 26, 2023	BUY	$39.39 - $51.28 $797,135 - $1.04 Million	20,237 Added 2.42%	857,856 $35 Million
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $182,238 - $237,892	-4,365 Reduced 0.52%	837,619 $42.9 Million
Q3 2022 Oct 18, 2022	BUY	$43.76 - $53.42 $423,246 - $516,678	9,672 Added 1.16%	841,984 $36.8 Million
Q2 2022 Jul 18, 2022	SELL	$46.53 - $55.17 $178,349 - $211,466	-3,833 Reduced 0.46%	832,312 $43.6 Million
Q1 2022 Apr 14, 2022	SELL	$45.75 - $56.69 $706,334 - $875,236	-15,439 Reduced 1.81%	836,145 $43.3 Million
Q4 2021 Jan 21, 2022	SELL	$41.32 - $61.25 $325,808 - $482,956	-7,885 Reduced 0.92%	851,584 $50.3 Million
Q3 2021 Oct 18, 2021	BUY	$39.25 - $50.42 $236,285 - $303,528	6,020 Added 0.71%	859,469 $37 Million
Q2 2021 Jul 16, 2021	BUY	$35.91 - $40.68 $572,836 - $648,927	15,952 Added 1.9%	853,449 $33.4 Million
Q1 2021 Apr 19, 2021	BUY	$33.49 - $37.77 $1.6 Million - $1.8 Million	47,726 Added 6.04%	837,497 $30.3 Million
Q4 2020 Jan 20, 2021	BUY	$33.47 - $42.56 $158,413 - $201,436	4,733 Added 0.6%	789,771 $29.1 Million
Q3 2020 Oct 14, 2020	SELL	$31.75 - $37.25 $200,596 - $235,345	-6,318 Reduced 0.8%	785,038 $28.8 Million
Q2 2020 Jul 13, 2020	SELL	$30.12 - $36.54 $340,295 - $412,828	-11,298 Reduced 1.41%	791,356 $25.9 Million
Q1 2020 Apr 14, 2020	SELL	$27.03 - $38.62 $299,816 - $428,373	-11,092 Reduced 1.36%	802,654 $26.2 Million
Q4 2019 Jan 14, 2020	BUY	$32.92 - $37.36 $562,602 - $638,482	17,090 Added 2.15%	813,746 $31.9 Million
Q3 2019 Oct 15, 2019	BUY	$32.49 - $42.13 $2.02 Million - $2.62 Million	62,201 Added 8.47%	796,656 $28.6 Million
Q2 2019 Jul 17, 2019	BUY	$36.98 - $41.52 $233,121 - $261,742	6,304 Added 0.87%	734,455 $31.8 Million
Q1 2019 Apr 12, 2019	SELL	$37.5 - $41.2 $858,112 - $942,779	-22,883 Reduced 3.05%	728,151 $30.9 Million
Q4 2018 Feb 01, 2019	SELL	$38.47 - $43.86 $2.15 Million - $2.45 Million	-55,770 Reduced 6.91%	751,034 $32.8 Million
Q3 2018 Oct 16, 2018	SELL	$34.47 - $41.81 $364,106 - $441,639	-10,563 Reduced 1.29%	806,804 $35.6 Million
Q2 2018 Jul 16, 2018	BUY	$32.98 - $35.16 $245,865 - $262,117	7,455 Added 0.92%	817,367 $29.7 Million
Q1 2018 Apr 16, 2018	SELL	$31.91 - $37.02 $4.76 Million - $5.53 Million	-149,276 Reduced 15.56%	809,912 $28.7 Million
Q4 2017 Feb 07, 2018	BUY	$33.26 - $35.29 $300,271 - $318,598	9,028 Added 0.95%	959,188 $34.7 Million
Q3 2017 Oct 17, 2017	BUY	$31.0 - $34.15 $29.5 Million - $32.4 Million	950,160	950,160 $33.9 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabal Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Sabal Trust CO with notifications on news.

Account